Solventum Corporation logo

Solventum Corporation (KB7)

Market Open
5 Dec, 16:43
XBER XBER
73. 40
+0.2
+0.27%
11.64B Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
73.2
Previous Close
Day Range
73 73.6
Year Range
55.2 81
Want to track KB7 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 83 days

Summary

KB7 trading today higher at €73.4, an increase of 0.27% from yesterday's close, completing a monthly increase of 22.74% or €13.6. Over the past 12 months, KB7 stock gained 17.44%.
KB7 is not paying dividends to its shareholders.
The last earnings report, released on Nov 06, 2025, missed the consensus estimates by -0.27%. On average, the company has fell short of earnings expectations by -0.09%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NYSE (USD).

KB7 Chart

Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Seekingalpha | 3 days ago
Solventum Corporation (SOLV) Presents at Stifel 2025 Healthcare Conference Transcript

Solventum Corporation (SOLV) Presents at Stifel 2025 Healthcare Conference Transcript

Solventum Corporation ( SOLV ) Stifel 2025 Healthcare Conference November 12, 2025 11:20 AM EST Company Participants Wayde McMillan - Chief Financial Officer Doug Bartlett Conference Call Participants Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Frederick Wise Stifel, Nicolaus & Company, Incorporated, Research Division Luckily, Wayde is not the Chief Executive Officer. He tells me, I'm not sure.

Seekingalpha | 3 weeks ago
SOLV vs. DHR: Which Stock Is the Better Value Option?

SOLV vs. DHR: Which Stock Is the Better Value Option?

Investors interested in Medical Services stocks are likely familiar with Solventum (SOLV) and Danaher (DHR). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 3 weeks ago

Solventum Corporation (KB7) FAQ

What is the stock price today?

The current price is €73.40.

On which exchange is it traded?

Solventum Corporation is listed on NYSE.

What is its stock symbol?

The ticker symbol is KB7.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 11.64B.

What is the earnings per share?

The EPS is 1.5.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has Solventum Corporation ever had a stock split?

No, there has never been a stock split.

Solventum Corporation Profile

- Industry
- Sector
Bryan C. Hanson CEO
XBER Exchange
US83444M1018 ISIN
US Country
22,000 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Solventum Corporation is a cutting-edge healthcare company established in 2023 and headquartered in Saint Paul, Minnesota. Specializing in the development, manufacture, and commercialization of diverse solutions aimed at addressing urgent customer and patient needs, the company operates across four main segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. Solventum Corporation stands out in the healthcare industry by offering a wide-ranging portfolio of innovative products and services, demonstrating its commitment to improving healthcare outcomes and enhancing the efficiency of medical and dental professions.

Products and Services

  • Medsurg: This segment targets the improvement of surgical and critical care through advanced products. Notably, it offers:
    • Advanced wound care for optimal healing.
    • Intravenous (I.V.) site management to prevent complications.
    • Sterilization assurance products for maintaining high hygiene standards.
    • Temperature management solutions to enhance patient comfort and outcomes.
    • Surgical supplies, including essentials for operating rooms.
    • High-quality stethoscopes for precise diagnostics.
    • Medical electrodes designed for accurate patient monitoring.
  • Dental Solutions: This segment delivers comprehensive dental and orthodontic products. Among these are:
    • Orthodontic brackets and aligners for a range of corrective procedures.
    • Restorative cements and bonding agents, essential for various dental works.
  • Health Information Systems: Focused on enhancing the efficiency of healthcare documentation and management through:
    • Computer-assisted, physician documentation tools to streamline processes.
    • Direct-to-bill and coding automation for accurate billing.
    • Classification methodologies to aid in patient data organization.
    • Speech recognition and data visualization platforms for better data interaction.
  • Purification and Filtration: Providing technologies that ensure purity and cleanliness, this segment manufactures:
    • Filters and purifiers for air and water, ensuring environmental safety.
    • Cartridges and membranes designed for specific filtration needs.

Contact Information

Address: 3M Center
Phone: 651-733-1110